Oligonucleotide-Mediated Inhibition of CD28 Expression Induces Human T Cell Hyporesponsiveness and Manifests Impaired Contact Hypersensitivity in Mice

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 200-208

  Tam, Robert C ^a   Phan, Uyen T ^a   Milovanovic, Tatjana ^a   Pai, Bharati ^a   Lim, Charmaine ^a   Bard, Josie ^a   He, Liyan ^a  

^a Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; OLIGONUCLEOTIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CONTACT DERMATITIS; DRUG EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; DERMATITIS, CONTACT; HUMANS; IMMUNE TOLERANCE; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES; T-LYMPHOCYTES;

EID: 0030639028     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74.
2. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
3. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
4. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
5. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845.
6. Sansom, D. M., and N. D. Hall. 1993. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vivo. Eur. J. Immunol. 23:295.
7. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573.
8. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
9. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
10. Wechsler, A. S., M. C. Gordon, U. Dendorfer, and K. P. LeClair. 1994. Induction of IL-8 in T cells uses the CD28 costimulatory pathway. J. Immunol. 153:2515.
11. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
12. Kao, H.-T., and J. R. Nevins. 1983. Transcription activation and subsequent control of the human heat shock gene during adenovirus infection. Mol. Cell. Biol. 3:2058.
13. Muller, G., J. Saloga, T. Germann, G. Schuler, J. Knop, and A. H. Enk. 1995. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155:4661.
14. Rus, V., A. Svetic, P. Nguyen, W. C. Gause, and C. S. Via. 1995. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host-disease. J. Immunol. 155:2396.
15. + T lymphocytes. J. Immunol. 148:1985.
16. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
17. Koyasu, S., T. Lawton, D. Novick, M. A. Recny, R. F. Siliciano, B. P. Wallner, and E. L. Reinherz. 1990. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 87:2603.
18. Lee, K. P., C. Taylor, B. Petryniak, L. A. Turka, C. H. June, and C. B. Thompson. 1990. The genomic organization of the CD28 gene: implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:344.
19. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607.
20. Tan, P., C. Anasetti, J. A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J. A. Ledbetter, and P. S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
21. L. Immunity 3:87.
22. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801.
23. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, and J. A. Bluestone. 1992. Long term survival of xenogeneic pancreatic islets induced by CTLA-4Ig. Science 257:789.
24. Enk, A. H., and S. I. Katz. 1995. Contact sensitivity as a model for T cell activation in skin. J. Invest. Dermatol. 105:80S.
25. Reiser, H., and E. E. Schneeberger. 1996. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur. J. Immunol. 26:880.
26. Tang, A., T. A. Judge, B. J. Nickoloff, and L. A. Turka. 1996. Suppression of murine allergic contact dermatitis by CTLA4Ig: tolerance induction of Th2 responses requires additional blockade of CD40 ligand. J. Immunol. 157:117.
27. Kalish, R. S. 1991. Recent developments in the pathogenesis of allergic contact dermatitis. Arch. Dermatol. Res. 127:1558.
28. Wei, L., K. M. Muller, J. H. Saurat, and C. Hauser. 1993. Lymphokine profiles in contact sensitivity induced by dinitrofluorobenzene and tolerance induced by dinitrothiocyanobenzene. Arch. Dermatol. Res. 284:427.
29. Ishii, N., K. Takahashi, H. Nakajima, S. Tanaka, and P. W. Askenase. 1994. DNFB contact sensitivity in BALB/c and C3H/He mice. J. Invest. Dermatol. 102:321.
30. + T cells, respectively, mediate and regulate contact hypersensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25:3006.
31. + T cells. J. Exp. Med. 183:1001.
32. + T cells in murine contact hypersensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144:4121.
33. Helene, C. 1991. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur. J. Cancer 27:1466.
34. Yaswen, P., M. R. Stampfer, K. Ghosh, and J. S. Cohen. 1993. Antisense Res. Dev. 3:67.
35. Perez, J. R., Y. Li, C. A. Stein, S. Majumder, A. van Oorschot, and R. Narayanan. 1994. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91:5957.
36. Maltese, J.-Y., H. W. Sharma, L. Vassilev, and R. Narayanan. 1995. Sequence context of antisense RelA/NFκB phosphoro-thioates determines specificity. Nucleic Acids Res. 23:1146.
37. 2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res. 22:3202.
38. Higgins, K., J. Perez, T. Coleman, K. Dorshkind, W. McNomas, U. Sarmiento, C. Rosen, and R. Narayanan. 1993. Antisense inhibition of the p65 subunit of NKκB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90:9901.
39. Blackburn, E. H. 1990. Telomeres: structure and synthesis. J. Biol. Chem. 265: 5919.
40. Shimizu, A., and T. Honjo. 1984. Immunoglobulin class switching. Cell 36:801.
41. Guvakova, M. A., L. A. Yakubov, I. Vlodavsky, J. L. Tonkinson, and C. A. Stein. 1995. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem. 270:2620.
42. Bock, L. C., L. C. Griffin, J. A. Latham, E. H. Vermaas, and J. J. Toole. 1992. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564.
43. Huizenga, D. E., and J. W. Szostak. 1995. A DNA aptamer that binds adenosine and ATP. Biochemistiy 34:656.
44. bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. Nucleic Acids Res. 22:2150.